Skip to main content

Table 2 Comparison between sarcopenic and non-sarcopenic patients

From: Prognostic value of sarcopenia in patients treated by Radiochemotherapy for locally advanced oesophageal cancer

 

Non Sarcopenic, n = 43 (%)

Sarcopenic, n = 54 (%)

p

Clinical parameters

Age

61.84 (10.90)

65.06 (11.20)

0,158

Sex

  

0,061

  M

32 (74.4%)

49 (90.7%)

 

  F

11 (25.6%)

5 (9.3%)

 

Histological subtype

  

0,005

  SCC

27 (62.8%)

48 (88.9%)

 

  OA

16 (37.2%)

6 (11.1%)

 

T

  

0,177

  1

0 (0%)

0 (0%)

 

  2

8 (20.0%)

5 (10.0%)

 

  3

32 (80.0%)

42 (84.0%)

 

  4

0 (0.0%)

3 (6.0%)

 

N

  

0,567

  0

9 (20.9%)

6 (11.3%)

 

  1

32 (74.4%)

43 (81.1%)

 

  2

1 (2.3%)

3 (5.7%)

 

  3

1 (2.3%)

1 (1.9%)

 

M

  

0,066

  0

39 (90.7%)

41 (75.9%)

 

  1

4 (9.3%)

13 (24.1%)

 

TNM Stage

  

0,053

  I-II

15 (34.9%)

10 (18.6%)

 

  III-IV

28 (65.1%)

44 (81.5%)

 

Tumour location

  

0,151

  Upper

6 (14.0%)

14 (25.9%)

 

  Mean

14 (32.6%)

21 (38.9%)

 

  Low

23 (53.5%)

19 (35.2%)

 

WHO Stage

  

< 0.001

  0

29 (67.4%)

17 (31.5%)

 

  1

11 (25.6%)

34 (63.0%)

 

  2

3 (7.0%)

2 (3.7%)

 

  3

0 (0.0%)

1 (1.9%)

 

Nutritional parameters

NRI

  

0,167

   > 97.5

21 (65.6%)

20 (43.5%)

 

  97.5–83.5

10 (31.2%)

22 (47.8%)

 

   < 83.5

1 (3.1%)

4 (8.7%)

 

Albumin levels (g/l)

39.62 (4.91)

38.42 (5.28)

0,301

Weight (kg)

75.23 (12.29)

64.74 (15.15)

< 0.001

Size (m)

1.70 [1.52, 1.85]

1.71 [1.45, 1.81]

0,112

BMI

26.52 (4.24)

22.14 (4.73)

< 0.001

Weight loss (%)

5.00 [0.00, 16.00]

8.00 [0.00, 32.00]

0,018

Anthropometric parameters

SML3 (cm2)

158.78 (31.28)

131.45 (20.64)

< 0.001

VFML3 (cm2)

139.85 [10.70, 418.29]

82.06 [5.80, 415.74]

0,005

SCFML3 (cm2)

145.89 [55.13, 432.99]

81.94 [4.20, 419.88]

< 0.001

Mean Density (HU)

31.33 (7.40)

30.00 (7.85)

0,398

SMI

55.47 (8.12)

44.91 (5.93)

< 0.001

18FDG-PET/CT parameters

SUVmax

11.20 [4.90, 26.40]

12.15 [3.60, 27.90]

0,17

TVol40

12.60 [2.00, 70.00]

17.85 [1.90, 140.40]

0,111

SUVmean

6.00 [1.90, 16.60]

7.10 [2.90, 16.50]

0,112

TLG

69.20 [7.40, 482.50]

121.50 [6.90, 1294.00]

0,044

  1. Note: Qualitative variable are described by distribution and frequencies (%); Gaussian variables are described by mean and standard deviation; non-Gaussian variables are described by mean [range]
  2. Abbreviation: SCC Squamous Cell Carcinoma, OA Oesophageal adenocarcinoma, NRI nutritional risk index, BMI Body Mass Index, SML3 L3 Skeletal Muscular Mass, VFML3 L3 Visceral Fat Mass, SCFML3 L3 Subcutaneous Fat Mass, SMI Skeletal Muscle Index, TNM Tumour, Node, Metastasis, WHO World Health Organization, TLG Total Lesion Glycolysis